Atlas Trials

68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours

Clinical trial NCT06155994 · COMPLETED

Trial details

NCT number
NCT06155994
Sponsor
Medical University Innsbruck
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2021-01-20
Primary completion
2023-06-30
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.